Lumexa Imaging (NASDAQ:LMRI) Upgraded to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Lumexa Imaging (NASDAQ:LMRI) from a hold rating to a buy rating in a report released on Sunday morning.

A number of other equities research analysts have also recently commented on LMRI. Weiss Ratings raised Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research note on Thursday, June 25th. Deutsche Bank Aktiengesellschaft set a $16.00 target price on Lumexa Imaging in a report on Thursday. Finally, Barclays reduced their price target on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Lumexa Imaging currently has an average rating of “Moderate Buy” and an average target price of $16.00.

Lumexa Imaging Stock Performance

Shares of Lumexa Imaging stock opened at $12.02 on Friday. The business has a 50-day simple moving average of $10.85 and a 200 day simple moving average of $10.89. Lumexa Imaging has a one year low of $6.45 and a one year high of $19.45. The company has a debt-to-equity ratio of 1.40, a current ratio of 1.44 and a quick ratio of 1.44. The firm has a market capitalization of $1.15 billion and a price-to-earnings ratio of -20.37.

Insiders Place Their Bets

In related news, Director Brett Brodnax purchased 35,000 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was acquired at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the purchase, the director owned 62,027 shares of the company’s stock, valued at approximately $449,695.75. This trade represents a 129.50% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Assetmark Inc. bought a new stake in Lumexa Imaging during the fourth quarter worth $36,000. Strs Ohio purchased a new position in Lumexa Imaging during the 1st quarter worth $38,000. PNC Financial Services Group Inc. bought a new stake in shares of Lumexa Imaging in the 1st quarter worth $63,000. State of Wyoming bought a new stake in shares of Lumexa Imaging in the 1st quarter worth $91,000. Finally, Barclays PLC purchased a new stake in shares of Lumexa Imaging in the fourth quarter valued at about $133,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).